Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
ZomedicaZOM |
$4.1M |
 |
Johnson & JohnsonJNJ |
-$62M |
 |
Mind Medicine (MindMed)MNMD |
-$44M |
 |
ModernaMRNA |
-$256B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Koenig Sheldon L. | Dec 17, 2024 | Sell | 12,447 | $2.466 | $31,000 |
| Halladay Benjamin | Dec 17, 2024 | Sell | 3,245 | $2.424 | $7,900 |
| Warren Eric | Dec 17, 2024 | Sell | 2,234 | $2.429 | $5,400 |
| Warren Eric | Nov 19, 2024 | Sell | 197 | $2.165 | $430 |
| Warren Eric | Oct 17, 2024 | Sell | 107 | $2.119 | $230 |
| Koenig Sheldon L. | Sep 17, 2024 | Sell | 14,550 | $1.796 | $26,000 |
| Warren Eric | Sep 17, 2024 | Sell | 2,608 | $1.783 | $4,700 |
| Warren Eric | Aug 19, 2024 | Sell | 211 | $1.946 | $410 |
| Warren Eric | Jul 17, 2024 | Sell | 108 | $2.587 | $280 |
| Foody Joanne M. | Jul 17, 2024 | Sell | 917 | $2.599 | $2,400 |
| Foody Joanne M. | Jun 18, 2024 | Sell | 3,285 | $2.867 | $9,400 |
| Warren Eric | Jun 18, 2024 | Sell | 2,540 | $2.856 | $7,300 |
| Warren Eric | May 17, 2024 | Sell | 192 | $2.483 | $480 |
| Warren Eric | Sep 20, 2023 | Sell | 742 | $1.245 | $920 |
| Warren Eric | Aug 18, 2023 | Sell | 243 | $1.414 | $340 |
| Warren Eric | Jul 19, 2023 | Sell | 106 | $1.585 | $170 |
| Warren Eric | Jun 21, 2023 | Sell | 603 | $1.483 | $890 |
| Warren Eric | May 17, 2023 | Sell | 219 | $1.624 | $360 |
| CARROLL J MARTIN | May 11, 2023 | Buy | 23,091 | $1.5714 | $36,000 |
| CARROLL J MARTIN | May 10, 2023 | Buy | 8,409 | $1.4919 | $13,000 |
| ROCAMBOLI STEPHEN | May 10, 2023 | Buy | 8,111 | $1.495 | $12,000 |
| Koenig Sheldon L. | May 9, 2023 | Buy | 20,000 | $1.2596 | $25,000 |
| Looker Benjamin | Apr 19, 2023 | Sell | 1,290 | $1.272 | $1,600 |
| Warren Eric | Apr 19, 2023 | Sell | 115 | $1.278 | $150 |
| Foody Joanne M. | Apr 19, 2023 | Sell | 938 | $1.271 | $1,200 |
| Foody Joanne M. | Mar 17, 2023 | Sell | 3,808 | $1.7819 | $6,800 |
| Koenig Sheldon L. | Mar 17, 2023 | Sell | 6,999 | $1.783 | $12,000 |
| Warren Eric | Mar 17, 2023 | Sell | 526 | $1.7823 | $940 |
| Warren Eric | Mar 7, 2023 | Sell | 5,090 | $5.055 | $26,000 |
| Koenig Sheldon L. | Mar 7, 2023 | Sell | 5,441 | $5.056 | $28,000 |
| Foody Joanne M. | Mar 7, 2023 | Sell | 3,884 | $5.065 | $20,000 |
| Looker Benjamin | Jan 18, 2023 | Sell | 6,347 | $6.996 | $44,000 |
| Foody Joanne M. | Jan 18, 2023 | Sell | 1,191 | $6.985 | $8,300 |
What's the latest insider transaction for Esperion Therapeutics?
The most recent insider transaction for Esperion Therapeutics was conducted by Koenig Sheldon L., who sold 12,447 shares on December 17, 2024 at a price of $2.47 per share.
Which insider bought the most ESPR stock over the last two years?
CARROLL J MARTIN has bought the most ESPR stock in the last 2 years, with a total value of $49,000.
Which insider has sold the most ESPR stock over the last two years?
Koenig Sheldon L. has sold the most ESPR stock in the last 2 years, with a total value of $97,000.
What is the total value of insider transactions for Esperion Therapeutics (ESPR) in the last 2 years?
The total value of insider transactions for Esperion Therapeutics in the last 2 years is negative, amounting to -$160,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Esperion Therapeutics' market confidence?
Over the last 2 years, insider transactions for Esperion Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
